Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pangaea Global AIDS Foundation was a non-profit organization focused on expanding access to HIV/AIDS prevention, care, and treatment in resource-limited settings. Established in 2001 and headquartered in San Francisco, the foundation provided technical assistance, clinical expertise, and policy guidance to international governments and healthcare providers. It was instrumental in the early scale-up of antiretroviral therapy (ART) programs, particularly in sub-Saharan Africa and Southeast Asia. The organization specialized in implementation science and health systems strengthening to ensure sustainable healthcare delivery. Pangaea worked closely with the San Francisco AIDS Foundation and was a key partner in global initiatives like PEPFAR. After nearly two decades of global health impact, the foundation officially ceased its operations in 2020.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pangaea Global AIDS Foundation.